Bylvay® (odevixibat) data
Bylvay® (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS
Bylvay® (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS
Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024
PARIS, FRANCE, 18 November, 2024 Ipsen ((Euronext: IPN, OTC:IPSEY) today announced data at the American Association for the Study of Liver Diseases (AASLD) assessing the long-t…